JMP Securities Upgrades Edwards Lifesciences (EW) to Market Outperform
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $90.81 -0.86%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
JMP Securities upgraded Edwards Lifesciences (NYSE: EW) from Market Perform to Market Outperform with a price target of $97.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $80.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Berenberg Upgrades Mobileye N.V (MBLY) to Buy
- Wells Fargo Upgrades Okta, Inc (OKTA) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
